Pre-Implantation Genetic Diagnosis/Screening is a reproductive technology used with In Vitro Fertilization (IVF) for screening and diagnosis of genetic diseases in early embryo prior to implantation and pregnancy. The most common type of PGD involves testing of embryos for a panel of common chromosomal abnormalities and using only normal healthy embryos to attempt a pregnancy..
Pre-Implantation Genetic Diagnosis/Screening was developed to prevent transfer of serious genetic disorders and to establish gender. It is a two stage process consisting of In-Vitro Fertilization (IVF) and genetic screening.
PGD can significantly reduce the chances for your baby to be affected with a specific genetic condition or chromosomal abnormality. We will be able to test for many different common genetic diseases in the near future.
We use the most advanced technology, NGS (Next-Generation Sequencing) to perform the PGS test:
Chances of conception (getting pregnant) are similar to IVF (30%-40%)
From a medical point of view there is no limit on the number of attempts but one has to consider emotional and financial stress involved in this treatment.
Whole genome Sequencing is a diagnostic tool used to identify the mutated gene(s) that cause genetic diseases in a family. The procedure is performed with the help of blood test. Mostly, after identifying the cause of genetic disease, the couples can opt for the Pre-Implantation Genetic Diagnosis (PGD) for Single Gene Disorders or can take the attempt to increase the chances of a successful IVF pregnancy (as in PGS for aneuploidy), It is in fact, a genetic test that facilitates embryos of the individual to be screened for the genetic disease that affects her family, before going for pregnancy.